.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Cerilliant
Merck
Federal Trade Commission
Harvard Business School
Cantor Fitzgerald
McKesson
Johnson and Johnson
Medtronic

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Process for preparing osmotic device
Abstract:An osmotic delivery system is disclosed for dispensing a useful agent. The system comprises a semipermeable wall surrounding a compartment housing the agent. The wall comprises a cellulose ether, an organic solvent soluble polymer, and optionally an aqueous soluble polymer. A passageway in the wall connects the interior of the system with the exterior for dispensing an agent from the system.
Inventor(s): Edgren; David (El Granada, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Filing Date:Feb 01, 1985
Application Number:06/697,598
Claims:1. A process for making an osmotic delivery system for delivering a beneficial drug to an environment of use, said process comprising:

(a) compressing a drug formulation into a solid mass of drug;

(b) coating the solid mass of drug with a wall-forming composition comprising (1) ethyl cellulose (2) a polyhydroxy polymer member selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, and hydroxyethyl cellulose, and (3) a carboxypolymer selected from the group consisting of carboxypolymethylene, poly(methylvinylether maleic anhydride), ethylene-acrylic acid copolymer, ethylene maleic acid anhydride copolymer, and methacrylic acid-ethylacrylic acid copolymer;

(c) reacting the polyhydroxy polymer and the carboxypolymer by heating the coated solid mass of drug to a temperature sufficient to cause the polyhydroxy polymer and the carboxypolymer to react and from with the ethyl cellulose a wall surrounding the solid mass of drug;

(d) cooling the wall surrounded solid mass of drug to room temperature; and,

(e) drilling a passageway through the wall for delivering the drug formulation from the delivery system.

2. The process for making an osmotic delivery system according to claim 1, wherein the wall-forming composition comprises 20 to 90 weight percent ethyl cellulose, 10 to 50 weight percent polyhydroxy polymer and 10 to 80 weight percent carboxypolymer per 100 weight percent wall forming composition.

3. The process for making an osmotic delivery system according to claim 1, wherein the polyhydroxy polymer and the carboxypolymer are reacted at a temperature of 60.degree. to 80.degree. C.

4. The process for making an osmotic delivery system according to claim 1, wherein the polyhydroxy polymer and the carboxypolymer are reacted at a temperature of 60.degree. to 80.degree. C. for 1 to 7 days.

5. The process for making an osmotic delivery system according to claim 1, wherein the reaction occurs in the wall.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Merck
Colorcon
Chubb
Cantor Fitzgerald
Cipla
Johnson and Johnson
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot